These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein. Goroncy-Bermes P, Dale JB, Beachey EH, Opferkuch W. Infect Immun; 1987 Oct; 55(10):2416-9. PubMed ID: 2443450 [Abstract] [Full Text] [Related]
23. [OF- and anti-OF test systems in microbiological and epidemiologic practice]. Beliakova IV, Totolian AA. Vestn Akad Med Nauk SSSR; 1989 Oct; (11):54-9. PubMed ID: 2483011 [Abstract] [Full Text] [Related]
24. Epitopes of streptococcal M proteins shared with cardiac myosin. Dale JB, Beachey EH. J Exp Med; 1985 Aug 01; 162(2):583-91. PubMed ID: 2410530 [Abstract] [Full Text] [Related]
25. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. Jones KF, Fischetti VA. J Exp Med; 1988 Mar 01; 167(3):1114-23. PubMed ID: 2450950 [Abstract] [Full Text] [Related]
26. Recombinant tetravalent group A streptococcal M protein vaccine. Dale JB, Chiang EY, Lederer JW. J Immunol; 1993 Aug 15; 151(4):2188-94. PubMed ID: 8345202 [Abstract] [Full Text] [Related]
27. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. Pruksakorn S, Galbraith A, Houghten RA, Good MF. J Immunol; 1992 Oct 15; 149(8):2729-35. PubMed ID: 1383324 [Abstract] [Full Text] [Related]
28. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease. Thakur A, Singhal S, Prakash K. J Med Microbiol; 1996 Dec 15; 45(6):483-9. PubMed ID: 8958254 [Abstract] [Full Text] [Related]
30. Protective immunity to the group A Streptococcus may be only strain specific. de Malmanche SA, Martin DR. Med Microbiol Immunol; 1994 Dec 15; 183(6):299-306. PubMed ID: 7596313 [Abstract] [Full Text] [Related]
35. [Antibodies reacting with thymus and skin epithelium and antibodies to cell nuclei in immunization with streptococcal group A polysaccharide conjugated with synthetic polyelectrolytes]. Ryzhikova EV, Nekrasov AV, Liampert IM, Kolesnikova VIu, Borodiiuk NA. Biull Eksp Biol Med; 1987 Jun 15; 103(6):707-10. PubMed ID: 2439143 [Abstract] [Full Text] [Related]
36. Mitogenic and antigenic properties of group A streptococcal M protein preparations. Knöll H, Kühnemund O, Havlícek J. Immunobiology; 1980 Jan 15; 156(4-5):537-48. PubMed ID: 6989752 [Abstract] [Full Text] [Related]
37. Interaction of group A type 1 streptococcal M protein with fibrinogen. Kühnemund O, Havlicek J, Knöll H, Sjöquist J, Köhler W. Acta Pathol Microbiol Immunol Scand B; 1985 Jun 15; 93(3):201-9. PubMed ID: 3898717 [Abstract] [Full Text] [Related]
38. Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates. Zhong W, Skwarczynski M, Toth I. Curr Drug Deliv; 2009 Oct 15; 6(5):520-7. PubMed ID: 19863488 [Abstract] [Full Text] [Related]
39. Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations. Brandt ER, Yarwood PJ, McMillan DJ, Vohra H, Currie B, Mammo L, Pruksakorn S, Saour J, Good MF. Int Immunol; 2001 Oct 15; 13(10):1335-43. PubMed ID: 11581178 [Abstract] [Full Text] [Related]